During the past decade, Guys & St Thomas Hospital; Department of Oncology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Guys & St Thomas Hospital; Department of Oncology" are "Breast Cancer" (2 trials), "Adenocarcinoma" (1 trials), "Advanced BRAFV600 Wild-type Melanoma" (1 trials), "Bronchial Diseases" (1 trials) and "Carcinoma" (1 trials). Many other conditions were trialed in "Guys & St Thomas Hospital; Department of Oncology" in a lesser frequency.

Most popular intervention types in "Guys & St Thomas Hospital; Department of Oncology" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Giredestrant" (2 trials), "LHRH Agonist" (2 trials), "Paclitaxel" (2 trials), "Pembrolizumab" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Guys & St Thomas Hospital; Department of Oncology" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Guys & St Thomas Hospital; Department of Oncology". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Guys & St Thomas Hospital; Department of Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Guys & St Thomas Hospital; Department of Oncology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".